Innovation

Novel device for treatment of bladder overactivity and other bladder pathologies

University of California System: University of California, Irvine
posted on 01/10/2012

A novel device based approach for the treatment of bladder pathologies including bladder overactivity and possibly interstitial cystitis.

Suggested Uses

Bladder overactivity, other bladder pathologies including interstitial cystitis.

Advantages

No systemic side effects, single-time outpatient treatment for bladder pathologies.


Innovation Details
 

Detailed Description

Urinary bladder pathology results from overactivity of the detrussor (bladder wall) musculature. Bladder pathology, including problems of bladder overactivity and possibly interstitial cystitis, are also thought to result from overactivity or improper activity of the innervations of the bladder.

Problems of bladder overactivity are typically resolved using medications to pharmacologically reduce overactivity of the bladder’s nerves. These medications, including anticholerinergic medications, are used by a very large population of patients. The medications are effective in most, but not all cases. Additionally, the medications have significant systemic side effects.

A novel technology to treat bladder overactivity and other bladder pathologies has been developed. This device based approach would require only a single time treatment, with minimal/no systemic side effects, and could be used to treat either the entire internal surface of the bladder wall, or selected portions of the bladder.

File Number: 22208 

Disease: Kidneys and Genito-Urinary System


IP Protection

Copyright: ©2012, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact the case manager at University of California System: University of California, Irvine for more information.

Request more info via email request more info
People

No people are currently associated with this innovation.


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,815 members 16,688 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...